Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world
- PMID: 23060099
- DOI: 10.1590/s0004-282x2012001000001
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world
Comment on
-
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.Arq Neuropsiquiatr. 2012 Oct;70(10):799-806. doi: 10.1590/s0004-282x2012001000009. Arq Neuropsiquiatr. 2012. PMID: 23060107
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
